New York Times (NYT) Financials

$55.41 -0.04 (-0.07%)

Closing price 03:59 PM Eastern

Extended Trading

$55.43 +0.02 (+0.04%)

As of 04:10 PM Eastern

Annual Income Statements for New York Times

This table shows New York Times' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/26/2021	12/27/2020	12/29/2019	12/30/2018	12/31/2017	12/25/2016	12/27/2015
Net Income / (Loss) Attributable to Common Shareholders	294	232	174	220	100	140	126	4.30	29	63
Consolidated Net Income / (Loss)	294	233	174	220	101	140	127	6.84	24	63
Net Income / (Loss) Continuing Operations	294	233	174	220	101	140	127	7.27	26	63
Total Pre-Tax Income	383	303	236	291	115	164	176	111	31	97
Total Operating Income	351	276	202	268	176	176	190	177	113	137
Total Gross Profit	1,276	1,177	1,099	1,035	824	824	796	1,413	926	961
Total Revenue	2,586	2,426	2,308	2,075	1,784	1,812	1,744	1,666	1,555	1,579
Operating Revenue	2,586	2,426	2,308	2,075	1,784	1,812	1,744	1,666	1,555	1,490
Total Cost of Revenue	1,310	1,249	1,209	1,040	959	988	948	253	629	618
Operating Cost of Revenue	1,310	1,249	1,209	1,040	959	988	948	253	629	618
Total Operating Expenses	925	901	897	767	648	648	606	1,236	813	825
Selling, General & Admin Expense	308	311	289	250	224	207	197	815	728	714
Marketing Expense	278	260	268	295	229	273	271	-	-	-
Research & Development Expense	248	229	204	161	133	106	84	-	-	-
Depreciation Expense	83	86	83	58	62	61	59	62	62	62
Other Operating Expenses / (Income)	-2.98	-0.61	15	0.00	0.00	-2.05	-4.85	359	6.73	49
Impairment Charge	0.00	15	4.07	0.00	0.00	-	-	-	-	-
Restructuring Charge	0.00	0.00	35	0.00	0.00	4.01	0.00	0.00	17	0.00
Other Special Charges / (Income)	11	0.00	0.00	3.83	0.00	0.00	-	-	-	0.00
Total Other Income / (Expense), net	32	26	34	22	-61	-11	-14	-65	-82	-40
Interest & Investment Income	36	24	41	0.00	5.00	0.00	11	19	-36	-0.78
Other Income / (Expense), net	-4.16	2.74	-6.66	-10	-89	-7.30	-8.27	-64	-11	-
Income Tax Expense	90	70	62	71	15	24	49	104	4.42	34
Net Income / (Loss) Attributable to Noncontrolling Interest	0.00	0.37	0.00	0.00	0.73	0.00	1.78	2.54	-5.24	-0.40
Basic Earnings per Share	$1.79	$1.41	$1.04	$1.31	$0.60	$0.84	$0.76	$0.03	$0.18	$0.38
Weighted Average Basic Shares Outstanding	164.43M	164.72M	166.87M	167.93M	166.97M	166.04M	164.85M	161.93M	161.13M	164.39M
Diluted Earnings per Share	$1.77	$1.40	$1.04	$1.31	$0.60	$0.83	$0.75	$0.03	$0.18	$0.38
Weighted Average Diluted Shares Outstanding	165.80M	165.66M	167.14M	168.53M	168.04M	167.55M	166.94M	164.26M	162.82M	166.42M
Weighted Average Basic & Diluted Shares Outstanding	163.30M	164.10M	164.47M	167.53M	167.44M	166.40M	165.40M	143.20M	161.50M	166.40M
Cash Dividends to Common per Share	$0.52	$0.44	$0.36	$0.28	$0.24	$0.20	$0.16	$0.16	$0.16	$0.16

This table shows New York Times' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/25/2022
Net Income / (Loss) Attributable to Common Shareholders	50	124	64	66	40	110	54	47	22	71	37
Consolidated Net Income / (Loss)	50	124	64	66	40	110	54	47	22	71	37
Net Income / (Loss) Continuing Operations	50	124	64	66	40	110	54	47	22	71	37
Total Pre-Tax Income	64	156	85	87	56	140	70	61	32	94	51
Total Operating Income	59	147	77	79	48	129	64	56	28	93	51
Total Gross Profit	301	389	308	302	277	355	287	281	254	335	253
Total Revenue	636	727	640	625	594	676	598	591	561	668	548
Operating Revenue	636	727	640	625	594	676	598	591	561	668	548
Total Cost of Revenue	335	338	332	323	317	321	311	310	307	332	295
Operating Cost of Revenue	335	338	332	323	317	321	311	310	307	332	295
Total Operating Expenses	243	242	232	223	229	226	224	225	226	242	202
Selling, General & Admin Expense	80	76	76	77	79	76	82	72	81	77	72
Marketing Expense	66	83	69	61	65	68	63	62	67	62	65
Research & Development Expense	67	62	61	62	63	58	57	56	57	55	50
Depreciation Expense	21	21	21	21	21	22	21	22	21	22	22
Other Operating Expenses / (Income)	4.45	-	0.00	-	-	-	-2.27	-	-	-	-7.13
Other Special Charges / (Income)	4.40	3.21	4.62	1.98	0.99	-	0.00	0.00	0.00	-	-
Total Other Income / (Expense), net	5.33	9.00	8.32	7.67	7.34	11	6.42	5.20	3.86	0.68	-0.18
Interest & Investment Income	9.97	-	9.37	-	-	-	5.74	-	-	-	-
Other Income / (Expense), net	-4.64	-1.03	-1.05	-1.02	-1.05	0.68	0.68	0.68	0.69	-1.76	-1.76
Income Tax Expense	14	32	21	22	15	30	16	14	9.44	23	14
Basic Earnings per Share	$0.30	$0.75	$0.39	$0.40	$0.25	$0.66	$0.33	$0.28	$0.14	$0.42	$0.22
Weighted Average Basic Shares Outstanding	163.78M	164.43M	164.42M	164.54M	164.63M	164.72M	164.57M	164.71M	164.98M	166.87M	166.43M
Diluted Earnings per Share	$0.30	$0.74	$0.39	$0.40	$0.24	$0.67	$0.32	$0.28	$0.13	$0.42	$0.22
Weighted Average Diluted Shares Outstanding	164.91M	165.80M	165.85M	165.51M	165.63M	165.66M	165.41M	165.04M	165.40M	167.14M	166.50M
Weighted Average Basic & Diluted Shares Outstanding	163.05M	163.30M	163.95M	164.23M	164.31M	164.10M	164.41M	164.34M	164.68M	164.47M	165.42M
Cash Dividends to Common per Share	$0.18	$0.13	$0.13	$0.13	$0.13	$0.11	$0.11	$0.11	$0.11	$0.18	$0.09

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/26/2021	12/27/2020	12/29/2019	12/30/2018	12/31/2017	12/25/2016	12/27/2015
Net Change in Cash & Equivalents	-88	68	-97	33	54	-12	60	75	-8.68	-70
Net Cash From Operating Activities	411	361	151	269	298	190	157	87	104	179
Net Cash From Continuing Operating Activities	411	361	151	269	298	190	157	87	104	179
Net Income / (Loss) Continuing Operations	294	233	174	220	101	140	127	6.84	24	63
Consolidated Net Income / (Loss)	294	233	174	220	101	140	127	6.84	24	63
Depreciation Expense	83	86	83	58	62	61	59	62	62	62
Amortization Expense	9.09	9.23	9.92	9.49	8.57	7.38	0.00	-	-	-
Non-Cash Adjustments To Reconcile Net Income	52	53	0.76	-20	79	-15	-35	-78	48	58
Changes in Operating Assets and Liabilities, net	-27	-20	-117	2.35	47	-2.80	5.52	96	-29	-3.84
Net Cash From Investing Activities	-306	-160	-74	-181	-199	93	-101	14	124	-31
Net Cash From Continuing Investing Activities	-306	-160	-74	-181	-199	93	-101	14	124	-31
Purchase of Property, Plant & Equipment	-29	-23	-37	-35	-34	-45	-77	-85	-30	-27
Acquisitions	0.00	0.00	-516	0.00	-33	0.00	0.00	-	-40	0.00
Purchase of Investments	-480	-286	-6.65	-763	-632	-572	-470	-467	-569	-824
Sale and/or Maturity of Investments	191	145	483	614	498	708	446	564	725	818
Other Investing Activities, net	13	4.75	2.48	3.72	2.85	3.27	0.43	1.32	38	1.93
Net Cash From Financing Activities	-193	-133	-174	-55	-45	-295	3.82	-26	-237	-218
Net Cash From Continuing Financing Activities	-193	-133	-174	-55	-45	-295	3.82	-26	-237	-218
Repurchase of Common Equity	-85	-45	-105	0.00	0.00	-	-	-	-16	-69
Payment of Dividends	-83	-70	-57	-45	-38	-32	-26	-26	-26	-27
Other Financing Activities, net	-25	-18	-12	-9.61	-6.54	-11	31	0.54	-6.44	-1.45
Cash Interest Paid	0.72	0.71	1.58	0.55	0.51	28	28	28	0.04	41
Cash Income Taxes Paid	113	72	110	66	24	30	-1.07	22	0.05	21

This table details how cash moves in and out of New York Times' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/25/2022
Net Change in Cash & Equivalents	-17	-5.01	-18	17	-82	53	-9.60	10	14	30	30
Net Cash From Operating Activities	99	152	126	80	53	137	104	69	51	66	69
Net Cash From Continuing Operating Activities	99	152	126	80	53	137	104	69	51	66	69
Net Income / (Loss) Continuing Operations	50	124	64	66	40	110	54	47	22	71	37
Consolidated Net Income / (Loss)	50	124	64	66	40	110	54	47	22	71	37
Depreciation Expense	21	21	21	21	21	22	21	22	21	22	22
Amortization Expense	2.33	2.32	2.31	2.24	2.22	2.05	2.20	2.50	2.49	2.46	2.49
Non-Cash Adjustments To Reconcile Net Income	26	20	8.96	13	10	22	7.90	12	12	36	-7.14
Changes in Operating Assets and Liabilities, net	-0.13	-16	29	-21	-20	-19	19	-13	-6.51	-65	15
Net Cash From Investing Activities	-8.34	-109	-101	-30	-66	-62	-92	-27	22	5.74	1.89
Net Cash From Continuing Investing Activities	-8.34	-109	-101	-30	-66	-62	-92	-27	22	5.74	1.89
Purchase of Property, Plant & Equipment	-9.24	-8.06	-7.06	-7.63	-6.42	-6.13	-5.75	-4.81	-5.99	-9.15	-8.80
Purchase of Investments	-168	-143	-152	-72	-113	-100	-142	-44	0.00	0.00	-0.00
Sale and/or Maturity of Investments	162	31	58	49	52	44	53	19	28	15	9.67
Other Investing Activities, net	7.23	11	-0.06	0.81	0.55	-	2.45	2.30	0.00	-	1.03
Net Cash From Financing Activities	-107	-48	-42	-34	-69	-21	-22	-32	-59	-41	-41
Net Cash From Continuing Financing Activities	-107	-48	-42	-34	-69	-21	-22	-32	-59	-41	-41
Repurchase of Common Equity	-59	-25	-18	-9.55	-32	-0.96	-	-13	-31	-25	-25
Payment of Dividends	-22	-21	-21	-21	-19	-18	-18	-18	-15	-15	-15
Other Financing Activities, net	-26	-2.02	-2.49	-2.70	-18	-1.47	-3.49	-0.63	-13	-0.90	-0.21

This table presents New York Times' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/26/2021	12/27/2020	12/29/2019	12/30/2018	12/31/2017	12/25/2016	12/27/2015
Total Assets	2,841	2,715	2,534	2,564	2,308	2,089	2,197	2,100	2,185	2,418
Total Current Assets	936	782	656	953	836	717	894	750	796	863
Cash & Equivalents	199	289	221	320	286	230	242	183	101	106
Short-Term Investments	366	162	126	341	309	202	371	309	450	508
Accounts Receivable	250	242	218	233	184	213	222	185	197	207
Prepaid Expenses	50	60	55	33	29	29	25	23	16	19
Other Current Assets	71	28	36	26	27	42	33	50	33	23
Plant, Property, & Equipment, net	489	514	554	575	595	627	639	641	597	632
Total Noncurrent Assets	1,416	1,419	1,324	2,964	877	745	664	709	792	923
Long-Term Investments	346	258	139	413	287	252	214	241	203	314
Goodwill	412	416	414	166	172	139	140	144	135	109
Intangible Assets	258	285	317	14	-	-	-	-	-	-
Noncurrent Deferred & Refundable Income Taxes	111	115	96	96	100	115	128	153	301	309
Employee Benefit Assets	71	83	70	88	-	-	-	-	-	-
Other Noncurrent Operating Assets	218	262	288	2,187	319	240	182	171	154	191
Total Liabilities & Shareholders' Equity	2,841	2,715	2,534	2,564	2,308	2,089	2,197	2,100	2,185	2,418
Total Liabilities	914	951	934	1,023	980	915	1,154	1,202	1,341	1,589
Total Current Liabilities	614	612	571	559	487	438	673	416	399	564
Accounts Payable	124	117	115	127	123	117	112	125	104	96
Accrued Expenses	125	148	136	146	137	124	120	111	131	121
Current Employee Benefit Liabilities	178	174	165	166	121	109	105	105	96	98
Other Current Liabilities	187	173	156	119	105	88	84	75	-	-
Total Noncurrent Liabilities	301	340	363	464	493	478	481	787	942	1,026
Noncurrent Employee Benefit Liabilities	215	239	252	331	365	351	403	454	617	691
Other Noncurrent Operating Liabilities	86	101	111	133	128	126	78	82	79	92
Total Equity & Noncontrolling Interests	1,927	1,763	1,600	1,541	1,328	1,174	1,043	897	844	828
Total Preferred & Common Equity	1,927	1,763	1,598	1,539	1,326	1,172	1,041	897	848	827
Total Common Equity	1,927	1,763	1,598	1,539	1,326	1,172	1,041	897	848	827
Common Stock	374	319	273	248	234	226	224	181	167	163
Retained Earnings	2,325	2,118	1,959	1,845	1,673	1,613	1,506	1,310	1,332	1,329
Treasury Stock	-406	-321	-276	-	-171	-171	-171	-171	-171	-156
Accumulated Other Comprehensive Income / (Loss)	-366	-353	-358	-383	-410	-495	-518	-423	-480	-509

This table presents New York Times' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022
Period end date	3/31/2025	9/30/2024	6/30/2024	3/31/2024	9/30/2023	6/30/2023	3/31/2023	9/25/2022
Total Assets	2,735	2,762	2,673	2,623	2,547	2,479	2,472	2,515
Total Current Assets	802	795	716	681	658	675	634	543
Cash & Equivalents	183	205	223	207	236	246	235	190
Short-Term Investments	339	288	188	172	163	171	139	103
Accounts Receivable	193	189	181	178	164	159	166	164
Prepaid Expenses	50	45	50	59	57	61	58	59
Other Current Assets	37	68	73	65	39	38	35	28
Plant, Property, & Equipment, net	483	495	503	508	524	531	546	561
Total Noncurrent Assets	1,451	1,472	1,454	1,434	1,365	1,273	1,292	1,411
Long-Term Investments	380	327	313	307	189	94	100	176
Goodwill	415	417	414	415	413	415	415	406
Intangible Assets	251	265	272	278	293	303	310	329
Noncurrent Deferred & Refundable Income Taxes	123	131	128	121	116	116	106	112
Other Noncurrent Operating Assets	281	332	328	313	353	346	361	388
Total Liabilities & Shareholders' Equity	2,735	2,762	2,673	2,623	2,547	2,479	2,472	2,515
Total Liabilities	850	910	868	875	891	872	895	973
Total Current Liabilities	555	590	543	545	554	532	540	556
Accounts Payable	122	137	121	121	120	111	122	120
Accrued Expenses	144	129	123	157	140	125	155	139
Current Employee Benefit Liabilities	96	146	124	89	138	139	100	145
Other Current Liabilities	194	177	175	178	157	157	164	152
Total Noncurrent Liabilities	295	320	325	330	337	340	355	417
Noncurrent Employee Benefit Liabilities	215	230	233	236	240	246	249	304
Other Noncurrent Operating Liabilities	80	90	92	94	97	93	106	113
Total Equity & Noncontrolling Interests	1,885	1,852	1,805	1,748	1,655	1,607	1,577	1,542
Total Preferred & Common Equity	1,885	1,852	1,805	1,748	1,653	1,605	1,575	1,540
Total Common Equity	1,885	1,852	1,805	1,748	1,653	1,605	1,575	1,540
Common Stock	365	352	338	317	298	286	273	263
Retained Earnings	2,345	2,223	2,180	2,137	2,026	1,991	1,963	1,918
Treasury Stock	-466	-382	-	-354	-320	-	-307	-251
Accumulated Other Comprehensive Income / (Loss)	-360	-342	-350	-352	-351	-352	-354	-390

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
Period end date	12/31/2024	12/31/2023	12/31/2022	12/26/2021	12/27/2020	12/29/2019	12/30/2018	12/31/2017	12/25/2016	12/27/2015
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.59%	5.10%	11.25%	16.33%	-1.58%	3.90%	4.72%	7.09%	-1.51%	-0.59%
EBITDA Growth	17.26%	30.04%	-11.30%	105.66%	-33.23%	-1.90%	38.26%	6.68%	-17.59%	15.62%
EBIT Growth	24.35%	42.86%	-24.17%	195.69%	-48.24%	-7.48%	61.88%	10.59%	-25.61%	48.55%
NOPAT Growth	26.61%	42.79%	-26.67%	31.82%	3.04%	8.56%	1,092.85%	-88.02%	8.62%	-13.75%
Net Income Growth	26.24%	33.84%	-20.94%	118.15%	-27.96%	9.81%	1,764.27%	-71.31%	-62.08%	94.53%
EPS Growth	26.43%	34.62%	-20.61%	118.33%	-27.71%	10.67%	2,400.00%	-83.33%	-52.63%	90.00%
Operating Cash Flow Growth	13.84%	139.32%	-44.00%	-9.68%	56.89%	20.86%	81.19%	-16.52%	-41.99%	122.48%
Free Cash Flow Firm Growth	13.06%	-80.95%	181.90%	-982.08%	52.87%	57.02%	226.69%	-171.79%	-31.17%	-32.27%
Invested Capital Growth	-3.67%	-5.36%	-53.48%	436.59%	-8.95%	4.27%	13.32%	22.65%	1.73%	-11.44%
Revenue Q/Q Growth	1.99%	0.36%	3.28%	-14.15%	31.56%	0.39%	1.18%	2.54%	-0.32%	0.00%
EBITDA Q/Q Growth	3.61%	11.46%	2.63%	39.45%	-32.85%	4.88%	26.24%	-19.12%	-16.37%	11.22%
EBIT Q/Q Growth	4.80%	15.99%	-0.09%	56.82%	-47.26%	2.15%	37.85%	-26.43%	-24.01%	22.67%
NOPAT Q/Q Growth	5.80%	17.33%	-0.56%	1.35%	3.64%	13.74%	436.76%	-88.55%	8.30%	5.46%
Net Income Q/Q Growth	4.81%	20.41%	0.52%	36.78%	-36.30%	8.73%	907.99%	-93.32%	-37.09%	39.66%
EPS Q/Q Growth	4.12%	21.74%	-0.95%	39.36%	-36.17%	9.21%	837.50%	-95.00%	-30.77%	35.71%
Operating Cash Flow Q/Q Growth	3.84%	24.45%	4.23%	-10.54%	8.35%	16.97%	184.67%	-47.80%	-33.70%	17.59%
Free Cash Flow Firm Q/Q Growth	6.08%	45.26%	387.48%	-857.39%	25.59%	4.79%	176.43%	-244.63%	-47.64%	-47.43%
Invested Capital Q/Q Growth	-1.58%	-1.26%	3.72%	460.61%	-2.40%	5.13%	2.57%	27.71%	25.72%	-5.85%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	49.36%	48.52%	47.63%	49.90%	46.22%	45.47%	45.65%	84.83%	59.54%	60.88%
EBITDA Margin	16.98%	15.43%	12.47%	15.64%	8.85%	13.04%	13.81%	10.46%	10.50%	12.55%
Operating Margin	13.58%	11.39%	8.75%	12.92%	9.88%	9.69%	10.90%	10.60%	7.24%	8.65%
EBIT Margin	13.42%	11.50%	8.46%	12.41%	4.88%	9.29%	10.43%	6.75%	6.53%	8.65%
Profit (Net Income) Margin	11.36%	9.59%	7.53%	10.60%	5.65%	7.72%	7.31%	0.41%	1.53%	3.98%
Tax Burden Percent	76.63%	76.92%	73.69%	75.72%	87.36%	85.11%	72.38%	6.15%	78.07%	64.95%
Interest Burden Percent	110.52%	108.45%	120.83%	112.79%	132.53%	97.73%	96.81%	98.98%	30.04%	70.84%
Effective Tax Rate	23.37%	23.08%	26.31%	24.28%	12.64%	14.89%	27.62%	93.47%	14.48%	35.05%
Return on Invested Capital (ROIC)	26.00%	19.61%	8.49%	14.29%	32.90%	31.14%	31.12%	3.07%	28.75%	25.08%
ROIC Less NNEP Spread (ROIC-NNEP)	22.95%	16.22%	22.16%	-103.53%	39.68%	32.64%	33.05%	4.02%	43.22%	31.17%
Return on Net Nonoperating Assets (RNNOA)	-10.08%	-5.77%	2.59%	1.04%	-24.84%	-18.51%	-17.98%	-2.28%	-25.90%	-17.00%
Return on Equity (ROE)	15.92%	13.84%	11.07%	15.34%	8.06%	12.63%	13.14%	0.79%	2.85%	8.07%
Cash Return on Invested Capital (CROIC)	29.74%	25.11%	81.48%	-122.87%	42.26%	26.96%	18.63%	-17.28%	27.03%	37.21%
Operating Return on Assets (OROA)	12.49%	10.63%	7.66%	10.57%	3.96%	7.85%	8.47%	5.24%	4.41%	5.48%
Return on Assets (ROA)	10.58%	8.87%	6.82%	9.03%	4.59%	6.53%	5.93%	0.32%	1.04%	2.52%
Return on Common Equity (ROCE)	15.92%	13.83%	11.06%	15.31%	8.05%	12.61%	13.13%	0.79%	2.85%	8.05%
Return on Equity Simple (ROE_SIMPLE)	15.25%	13.20%	10.88%	14.30%	7.61%	11.94%	12.25%	0.76%	2.81%	7.60%
Net Operating Profit after Tax (NOPAT)	269	213	149	203	154	149	138	12	96	89
NOPAT Margin	10.40%	8.76%	6.45%	9.78%	8.63%	8.25%	7.89%	0.69%	6.20%	5.62%
Net Nonoperating Expense Percent (NNEP)	3.06%	3.39%	-13.67%	117.83%	-6.79%	-1.51%	-1.93%	-0.95%	-14.47%	-6.09%
Return On Investment Capital (ROIC_SIMPLE)	13.96%	12.05%	9.30%	-	-	-	-	-	-	-
Cost of Revenue to Revenue	50.64%	51.48%	52.37%	50.10%	53.78%	54.53%	54.35%	15.17%	40.46%	39.12%
SG&A Expenses to Revenue	11.91%	12.82%	12.53%	12.05%	12.53%	11.41%	11.27%	48.94%	46.83%	45.20%
R&D to Revenue	9.60%	9.43%	8.85%	7.75%	7.48%	5.87%	4.82%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	35.78%	37.13%	38.88%	36.98%	36.33%	35.78%	34.75%	74.23%	52.29%	52.23%
Earnings before Interest and Taxes (EBIT)	347	279	195	258	87	168	182	112	102	137
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	439	374	288	325	158	236	241	174	163	198
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.42	4.51	3.28	5.03	6.26	4.36	3.39	3.17	2.42	2.49
Price to Tangible Book Value (P/TBV)	6.77	7.49	6.05	5.69	7.19	4.95	3.92	3.77	2.88	2.87
Price to Revenue (P/Rev)	3.29	3.28	2.27	3.73	4.65	2.82	2.02	1.71	1.32	1.30
Price to Earnings (P/E)	28.97	34.22	30.15	35.15	82.92	36.53	28.06	662.05	70.72	32.56
Dividend Yield	0.96%	0.87%	1.07%	0.59%	0.46%	0.62%	0.75%	0.91%	1.25%	1.26%
Earnings Yield	3.45%	2.92%	3.32%	2.84%	1.21%	2.74%	3.56%	0.15%	1.41%	3.07%
Enterprise Value to Invested Capital (EV/IC)	7.49	6.87	4.27	2.78	16.64	9.04	6.29	5.70	4.57	4.71
Enterprise Value to Revenue (EV/Rev)	2.94	2.99	2.06	3.21	4.16	2.44	1.70	1.42	0.99	0.99
Enterprise Value to EBITDA (EV/EBITDA)	17.31	19.35	16.53	20.52	47.03	18.75	12.27	13.55	9.47	7.89
Enterprise Value to EBIT (EV/EBIT)	21.91	25.96	24.37	25.86	85.20	26.33	16.25	21.02	15.22	11.45
Enterprise Value to NOPAT (EV/NOPAT)	28.25	34.09	31.98	32.82	48.20	29.65	21.48	204.65	16.04	17.64
Enterprise Value to Operating Cash Flow (EV/OCF)	18.51	20.09	31.58	24.75	24.91	23.33	18.82	27.23	14.88	8.74
Enterprise Value to Free Cash Flow (EV/FCFF)	24.70	26.61	3.33	0.00	37.52	34.24	35.88	0.00	17.07	11.89
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.24	0.28	0.29	0.52
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.28	0.29	0.29
Financial Leverage	-0.44	-0.36	0.12	-0.01	-0.63	-0.57	-0.54	-0.57	-0.60	-0.55
Leverage Ratio	1.51	1.56	1.62	1.70	1.76	1.93	2.21	2.46	2.75	3.20
Compound Leverage Factor	1.66	1.69	1.96	1.92	2.33	1.89	2.14	2.44	0.83	2.27
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	19.57%	21.80%	22.63%	34.23%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	19.57%	0.00%	0.00%	14.95%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	21.80%	22.63%	19.28%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.13%	0.13%	0.20%	0.16%	0.14%	0.01%	-0.33%	0.14%
Common Equity to Total Capital	100.00%	100.00%	99.87%	99.87%	99.80%	99.84%	80.29%	78.19%	77.69%	65.63%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	1.05	1.44	1.51	2.18
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-2.38	-2.77	-3.10	-2.50
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.44	1.51	1.23
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	1.84	21.68	2.56	4.86
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-4.16	-41.83	-5.25	-5.59
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	21.68	2.56	2.74
Altman Z-Score	8.18	7.42	5.66	6.87	7.18	5.73	3.98	3.45	2.86	2.53
Noncontrolling Interest Sharing Ratio	0.00%	0.06%	0.13%	0.16%	0.18%	0.17%	0.10%	-0.20%	-0.11%	0.24%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.53	1.28	1.15	1.70	1.72	1.64	1.33	1.80	2.00	1.53
Quick Ratio	1.33	1.13	0.99	1.60	1.60	1.48	1.24	1.63	1.87	1.46
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	308	272	1,429	-1,745	198	129	82	-65	91	132
Operating Cash Flow to CapEx	1,407.16%	1,590.80%	407.69%	776.91%	864.80%	417.90%	202.77%	102.31%	345.16%	664.10%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	33.87	4.97	-3.29	2.60	3.37
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	49.71	9.48	4.38	2.98	4.59
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	37.82	4.81	0.10	2.12	3.90
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.93	0.92	0.91	0.85	0.81	0.85	0.81	0.78	0.68	0.63
Accounts Receivable Turnover	10.51	10.55	10.25	9.96	8.98	8.32	8.56	8.71	7.69	7.52
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	5.16	4.54	4.09	3.55	2.92	2.86	2.73	2.69	2.53	2.43
Accounts Payable Turnover	10.89	10.79	10.00	8.31	8.00	8.66	8.00	2.20	6.28	6.49
Days Sales Outstanding (DSO)	34.72	34.60	35.61	36.64	40.63	43.89	42.62	41.88	47.47	48.52
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	33.52	33.84	36.49	43.93	45.61	42.13	45.64	166.09	58.15	56.27
Cash Conversion Cycle (CCC)	1.20	0.77	-0.88	-7.29	-4.98	1.76	-3.01	-124.21	-10.69	-7.75
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,015	1,054	1,114	2,394	446	490	470	415	338	332
Invested Capital Turnover	2.50	2.24	1.32	1.46	3.81	3.78	3.94	4.43	4.64	4.46
Increase / (Decrease) in Invested Capital	-39	-60	-1,280	1,948	-44	20	55	77	5.77	-43
Enterprise Value (EV)	7,601	7,244	4,759	6,660	7,421	4,431	2,956	2,362	1,546	1,565
Market Capitalization	8,512	7,953	5,244	7,733	8,301	5,113	3,527	2,844	2,056	2,059
Book Value per Share	$11.75	$10.72	$9.66	$9.17	$7.93	$7.06	$6.31	$5.53	$5.26	$5.11
Tangible Book Value per Share	$7.67	$6.46	$5.24	$8.09	$6.90	$6.22	$5.46	$4.65	$4.43	$4.43
Total Capital	1,927	1,763	1,600	1,541	1,328	1,174	1,296	1,148	1,091	1,260
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	254	250	247	431
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	250	247	243
Net Debt	-912	-709	-486	-1,074	-882	-684	-573	-483	-506	-496
Capital Expenditures (CapEx)	29	23	37	35	34	45	77	85	30	27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-243	-281	-263	-267	-246	-153	-139	-157	-153	-126
Debt-free Net Working Capital (DFNWC)	323	170	84	394	349	279	474	334	397	487
Net Working Capital (NWC)	323	170	84	394	349	279	221	334	397	299
Net Nonoperating Expense (NNE)	-25	-20	-25	-17	53	9.47	10	4.70	73	26
Net Nonoperating Obligations (NNO)	-912	-709	-486	853	-882	-684	-573	-483	-506	-496
Total Depreciation and Amortization (D&A)	92	95	93	67	71	68	59	62	62	62
Debt-free, Cash-free Net Working Capital to Revenue	-9.40%	-11.60%	-11.39%	-12.89%	-13.80%	-8.45%	-7.94%	-9.45%	-9.82%	-7.98%
Debt-free Net Working Capital to Revenue	12.48%	7.01%	3.66%	18.97%	19.57%	15.40%	27.19%	20.06%	25.55%	30.86%
Net Working Capital to Revenue	12.48%	7.01%	3.66%	18.97%	19.57%	15.40%	12.65%	20.06%	25.55%	18.93%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.79	$1.41	$1.04	$1.31	$0.60	$0.84	$0.76	$0.03	$0.18	$0.38
Adjusted Weighted Average Basic Shares Outstanding	164.43M	164.72M	166.87M	167.93M	166.97M	166.04M	164.85M	161.93M	161.13M	164.39M
Adjusted Diluted Earnings per Share	$1.77	$1.40	$1.04	$1.31	$0.60	$0.83	$0.75	$0.03	$0.18	$0.38
Adjusted Weighted Average Diluted Shares Outstanding	165.80M	165.66M	167.14M	168.53M	168.04M	167.55M	166.94M	164.26M	162.82M	166.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	163.30M	164.10M	164.47M	167.53M	167.44M	166.40M	165.92M	164.82M	161.20M	160.21M
Normalized Net Operating Profit after Tax (NOPAT)	277	224	177	206	154	153	138	124	110	89
Normalized NOPAT Margin	10.72%	9.24%	7.69%	9.92%	8.63%	8.43%	7.89%	7.42%	7.10%	5.62%
Pre Tax Income Margin	14.83%	12.47%	10.22%	14.00%	6.47%	9.08%	10.10%	6.68%	1.96%	6.13%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	44.05	10.98	5.68	2.92	3.50
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	39.12	8.31	0.58	2.77	2.27
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	32.16	6.30	1.40	2.05	2.81
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	27.22	3.63	-3.70	1.90	1.58
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.20%	30.00%	32.66%	20.61%	38.12%	22.58%	20.73%	380.34%	108.66%	42.33%
Augmented Payout Ratio	57.14%	49.14%	93.07%	20.61%	38.12%	22.58%	20.73%	380.34%	174.48%	152.59%

This table displays calculated financial ratios and metrics derived from New York Times' official financial filings.

Metric	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022
Period end date	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022	9/25/2022
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	7.05%	7.46%	6.99%	5.80%	5.93%	1.30%	9.25%	6.33%	4.34%	12.34%	7.58%
EBITDA Growth	10.70%	9.95%	12.16%	25.18%	35.21%	33.41%	19.61%	14.92%	79.97%	6.85%	16.07%
EBIT Growth	14.23%	12.25%	17.78%	38.84%	65.36%	42.15%	30.44%	12.83%	500.27%	-0.20%	6.21%
NOPAT Growth	29.44%	14.62%	18.84%	40.29%	78.94%	44.72%	32.53%	14.32%	285.49%	-1.25%	2.88%
Net Income Growth	22.60%	12.23%	19.64%	40.72%	81.07%	55.74%	46.42%	-24.61%	372.40%	1.28%	-33.00%
EPS Growth	25.00%	10.45%	21.88%	42.86%	84.62%	59.52%	45.45%	-24.32%	333.33%	-2.33%	-31.25%
Operating Cash Flow Growth	86.68%	11.12%	20.31%	16.19%	4.63%	107.91%	51.46%	124.14%	446.07%	10.28%	-30.51%
Free Cash Flow Firm Growth	64.43%	-3.80%	70.46%	132.89%	221.29%	-88.05%	109.01%	105.62%	88.65%	171.96%	-1,026.79%
Invested Capital Growth	-7.46%	-3.67%	-3.35%	-1.44%	-3.69%	-5.36%	-0.58%	0.93%	8.04%	-53.48%	151.46%
Revenue Q/Q Growth	-12.48%	13.50%	2.41%	5.23%	-12.16%	13.01%	1.27%	5.37%	-16.00%	21.88%	-1.44%
EBITDA Q/Q Growth	-54.02%	71.37%	-2.52%	44.12%	-54.33%	74.82%	8.79%	55.67%	-54.94%	56.74%	4.53%
EBIT Q/Q Growth	-62.92%	92.40%	-3.46%	65.84%	-63.56%	101.89%	13.80%	97.51%	-68.67%	85.25%	-1.56%
NOPAT Q/Q Growth	-61.04%	101.43%	-3.17%	70.32%	-65.50%	108.84%	14.31%	117.25%	-72.10%	91.25%	-1.40%
Net Income Q/Q Growth	-59.95%	92.89%	-2.13%	62.16%	-63.34%	105.62%	15.12%	108.66%	-68.47%	93.31%	-40.73%
EPS Q/Q Growth	-59.46%	89.74%	-2.50%	66.67%	-64.18%	109.38%	14.29%	115.38%	-69.05%	90.91%	-40.54%
Operating Cash Flow Q/Q Growth	-34.68%	20.87%	56.43%	51.15%	-61.12%	30.87%	51.07%	36.12%	-22.74%	-4.66%	123.57%
Free Cash Flow Firm Q/Q Growth	-19.75%	65.72%	23.92%	-0.22%	-53.05%	193.65%	69.29%	151.96%	-104.63%	321.38%	-5.67%
Invested Capital Q/Q Growth	-3.23%	-1.58%	-4.56%	1.82%	0.73%	-1.26%	-2.68%	-0.50%	-1.02%	3.72%	-1.19%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.38%	53.48%	48.16%	48.36%	46.66%	52.51%	48.00%	47.55%	45.28%	50.25%	46.16%
EBITDA Margin	12.22%	23.26%	15.40%	16.18%	11.82%	22.73%	14.69%	13.68%	9.26%	17.26%	13.42%
Operating Margin	9.22%	20.18%	11.99%	12.70%	8.13%	19.08%	10.62%	9.44%	4.98%	13.93%	9.31%
EBIT Margin	8.49%	20.04%	11.82%	12.54%	7.96%	19.18%	10.74%	9.56%	5.10%	13.67%	8.99%
Profit (Net Income) Margin	7.79%	17.03%	10.02%	10.48%	6.80%	16.30%	8.96%	7.88%	3.98%	10.60%	6.69%
Tax Burden Percent	77.46%	79.49%	75.42%	75.26%	72.62%	78.82%	76.61%	76.38%	70.28%	75.56%	72.03%
Interest Burden Percent	118.47%	106.89%	112.38%	111.09%	117.74%	107.83%	108.93%	108.00%	111.10%	102.67%	103.21%
Effective Tax Rate	22.54%	20.51%	24.58%	24.74%	27.38%	21.18%	23.39%	23.62%	29.72%	24.44%	27.97%
Return on Invested Capital (ROIC)	18.36%	40.09%	21.84%	21.89%	13.43%	33.67%	18.38%	15.63%	7.68%	13.86%	19.98%
ROIC Less NNEP Spread (ROIC-NNEP)	17.84%	39.21%	20.95%	20.96%	12.51%	32.24%	17.45%	14.81%	7.11%	14.14%	20.00%
Return on Net Nonoperating Assets (RNNOA)	-7.80%	-17.22%	-8.41%	-7.58%	-4.37%	-11.46%	-5.76%	-4.53%	-2.20%	1.65%	-10.03%
Return on Equity (ROE)	10.56%	22.87%	13.43%	14.31%	9.06%	22.21%	12.61%	11.10%	5.49%	15.51%	9.95%
Cash Return on Invested Capital (CROIC)	35.09%	29.74%	27.64%	23.96%	24.83%	25.11%	17.50%	14.57%	7.67%	81.48%	-66.24%
Operating Return on Assets (OROA)	8.33%	18.65%	11.29%	12.14%	7.68%	17.73%	10.26%	9.06%	4.75%	12.38%	8.07%
Return on Assets (ROA)	7.64%	15.85%	9.57%	10.15%	6.57%	15.07%	8.56%	7.47%	3.71%	9.60%	6.00%
Return on Common Equity (ROCE)	10.56%	22.87%	13.42%	14.30%	9.05%	22.19%	12.60%	11.08%	5.48%	15.49%	9.94%
Return on Equity Simple (ROE_SIMPLE)	16.07%	0.00%	15.14%	14.95%	14.35%	0.00%	11.69%	10.98%	12.16%	0.00%	11.23%
Net Operating Profit after Tax (NOPAT)	45	117	58	60	35	102	49	43	20	70	37
NOPAT Margin	7.14%	16.04%	9.04%	9.56%	5.91%	15.04%	8.14%	7.21%	3.50%	10.53%	6.71%
Net Nonoperating Expense Percent (NNEP)	0.52%	0.88%	0.89%	0.94%	0.92%	1.43%	0.93%	0.82%	0.57%	-0.28%	-0.02%
Return On Investment Capital (ROIC_SIMPLE)	2.41%	6.05%	-	-	-	5.77%	-	-	-	4.39%	-
Cost of Revenue to Revenue	52.62%	46.52%	51.84%	51.64%	53.34%	47.49%	52.00%	52.45%	54.72%	49.75%	53.84%
SG&A Expenses to Revenue	12.57%	10.46%	11.90%	12.30%	13.27%	11.22%	13.68%	12.23%	14.45%	11.50%	13.14%
R&D to Revenue	10.46%	8.50%	9.53%	9.95%	10.64%	8.62%	9.60%	9.49%	10.18%	8.31%	9.22%
Operating Expenses to Revenue	38.16%	33.30%	36.18%	35.66%	38.52%	33.43%	37.38%	38.11%	40.30%	36.31%	36.85%
Earnings before Interest and Taxes (EBIT)	54	146	76	78	47	130	64	56	29	91	49
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	78	169	99	101	70	154	88	81	52	115	74
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	4.28	4.42	4.92	4.65	4.04	4.51	4.04	3.99	4.00	3.28	2.95
Price to Tangible Book Value (P/TBV)	6.62	6.77	7.79	7.50	6.70	7.49	7.06	7.21	7.41	6.05	5.65
Price to Revenue (P/Rev)	3.07	3.29	3.60	3.37	2.87	3.28	2.77	2.70	2.70	2.27	2.04
Price to Earnings (P/E)	26.64	28.97	32.58	31.15	28.21	34.22	34.58	36.30	32.86	30.15	26.30
Dividend Yield	1.05%	0.96%	0.86%	0.90%	1.02%	0.87%	0.98%	0.98%	0.94%	1.07%	1.17%
Earnings Yield	3.75%	3.45%	3.07%	3.21%	3.54%	2.92%	2.89%	2.75%	3.04%	3.32%	3.80%
Enterprise Value to Invested Capital (EV/IC)	7.30	7.49	8.05	7.09	6.01	6.87	5.71	5.37	5.28	4.27	3.80
Enterprise Value to Revenue (EV/Rev)	2.73	2.94	3.27	3.08	2.59	2.99	2.52	2.49	2.50	2.06	1.83
Enterprise Value to EBITDA (EV/EBITDA)	16.06	17.31	19.59	18.57	16.25	19.35	18.16	18.33	18.72	16.53	14.56
Enterprise Value to EBIT (EV/EBIT)	20.27	21.91	25.07	24.00	21.43	25.96	25.35	26.12	26.56	24.37	20.89
Enterprise Value to NOPAT (EV/NOPAT)	25.65	28.25	32.64	31.29	27.99	34.09	33.67	34.82	35.61	31.98	27.28
Enterprise Value to Operating Cash Flow (EV/OCF)	15.70	18.51	21.00	20.50	17.58	20.09	21.05	23.17	26.94	31.58	28.24
Enterprise Value to Free Cash Flow (EV/FCFF)	19.98	24.70	28.61	29.39	23.75	26.61	32.55	37.04	71.51	3.33	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Financial Leverage	-0.44	-0.44	-0.40	-0.36	-0.35	-0.36	-0.33	-0.31	-0.31	0.12	-0.50
Leverage Ratio	1.47	1.51	1.51	1.51	1.53	1.56	1.58	1.59	1.63	1.62	1.66
Compound Leverage Factor	1.75	1.61	1.70	1.68	1.80	1.68	1.72	1.71	1.81	1.67	1.71
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.12%	0.12%	0.13%	0.13%	0.13%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	99.88%	99.88%	99.87%	99.87%	99.87%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Altman Z-Score	8.03	7.95	8.24	8.05	7.05	7.23	6.70	6.63	6.35	5.52	4.82
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.06%	0.06%	0.06%	0.06%	0.13%	0.13%	0.13%	0.13%	0.13%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.44	1.53	1.35	1.32	1.25	1.28	1.19	1.27	1.17	1.15	0.98
Quick Ratio	1.29	1.33	1.16	1.09	1.02	1.13	1.02	1.08	1.00	0.99	0.82
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	125	155	94	76	76	161	55	32	-62	1,350	-610
Operating Cash Flow to CapEx	1,072.73%	1,882.55%	1,777.45%	1,051.52%	826.26%	2,227.05%	1,815.17%	1,436.49%	847.62%	717.47%	782.33%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.98	0.93	0.96	0.97	0.97	0.92	0.96	0.95	0.93	0.91	0.90
Accounts Receivable Turnover	14.20	10.51	14.37	14.66	14.31	10.55	14.76	14.13	12.83	10.25	13.62
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	5.31	5.16	4.98	4.82	4.67	4.54	4.46	4.31	4.17	4.09	3.92
Accounts Payable Turnover	10.96	10.89	10.06	10.98	10.38	10.79	10.53	11.06	9.21	10.00	9.71
Days Sales Outstanding (DSO)	25.71	34.72	25.41	24.90	25.50	34.60	24.73	25.83	28.45	35.61	26.80
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	33.31	33.52	36.27	33.25	35.17	33.84	34.66	32.99	39.65	36.49	37.60
Cash Conversion Cycle (CCC)	-7.61	1.20	-10.86	-8.35	-9.68	0.77	-9.93	-7.16	-11.20	-0.88	-10.81
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	983	1,015	1,032	1,081	1,062	1,054	1,067	1,097	1,102	1,114	1,074
Invested Capital Turnover	2.57	2.50	2.42	2.29	2.27	2.24	2.26	2.17	2.20	1.32	2.98
Increase / (Decrease) in Invested Capital	-79	-39	-36	-16	-41	-60	-6.26	10	82	-1,280	647
Enterprise Value (EV)	7,168	7,601	8,301	7,669	6,380	7,244	6,099	5,891	5,820	4,759	4,083
Market Capitalization	8,070	8,512	9,121	8,393	7,067	7,953	6,685	6,400	6,293	5,244	4,550
Book Value per Share	$11.54	$11.75	$11.28	$10.99	$10.62	$10.72	$10.06	$9.75	$9.57	$9.66	$9.27
Tangible Book Value per Share	$7.46	$7.67	$7.13	$6.81	$6.41	$6.46	$5.76	$5.39	$5.17	$5.24	$4.84
Total Capital	1,885	1,927	1,852	1,805	1,748	1,763	1,655	1,607	1,577	1,600	1,542
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Net Debt	-902	-912	-820	-724	-686	-709	-588	-510	-474	-486	-469
Capital Expenditures (CapEx)	9.24	8.06	7.06	7.63	6.42	6.13	5.75	4.81	5.99	9.15	8.80
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-275	-243	-288	-238	-243	-281	-294	-274	-281	-263	-305
Debt-free Net Working Capital (DFNWC)	247	323	205	173	136	170	104	143	94	84	-13
Net Working Capital (NWC)	247	323	205	173	136	170	104	143	94	84	-13
Net Nonoperating Expense (NNE)	-4.13	-7.16	-6.27	-5.77	-5.33	-8.54	-4.92	-3.97	-2.71	-0.51	0.13
Net Nonoperating Obligations (NNO)	-902	-912	-820	-724	-686	-709	-588	-510	-474	-486	-469
Total Depreciation and Amortization (D&A)	24	23	23	23	23	24	24	24	23	24	24
Debt-free, Cash-free Net Working Capital to Revenue	-10.48%	-9.40%	-11.34%	-9.56%	-9.86%	-11.60%	-12.17%	-11.58%	-12.04%	-11.39%	-13.66%
Debt-free Net Working Capital to Revenue	9.39%	12.48%	8.10%	6.94%	5.55%	7.01%	4.31%	6.03%	4.03%	3.66%	-0.56%
Net Working Capital to Revenue	9.39%	12.48%	8.10%	6.94%	5.55%	7.01%	4.31%	6.03%	4.03%	3.66%	-0.56%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$0.30	$0.75	$0.39	$0.40	$0.25	$0.66	$0.33	$0.28	$0.14	$0.42	$0.22
Adjusted Weighted Average Basic Shares Outstanding	163.78M	164.43M	164.42M	164.54M	164.63M	164.72M	164.57M	164.71M	164.98M	166.87M	166.43M
Adjusted Diluted Earnings per Share	$0.30	$0.74	$0.39	$0.40	$0.24	$0.67	$0.32	$0.28	$0.13	$0.42	$0.22
Adjusted Weighted Average Diluted Shares Outstanding	164.91M	165.80M	165.85M	165.51M	165.63M	165.66M	165.41M	165.04M	165.40M	167.14M	166.50M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	163.05M	163.30M	163.95M	164.23M	164.31M	164.10M	164.41M	164.34M	164.68M	164.47M	165.42M
Normalized Net Operating Profit after Tax (NOPAT)	49	119	61	61	36	102	51	52	20	70	37
Normalized NOPAT Margin	7.68%	16.39%	9.58%	9.80%	6.03%	15.04%	8.46%	8.86%	3.50%	10.53%	6.71%
Pre Tax Income Margin	10.06%	21.42%	13.28%	13.93%	9.37%	20.68%	11.70%	10.32%	5.66%	14.03%	9.28%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	28.49%	28.20%	28.52%	28.41%	29.25%	30.00%	34.29%	35.79%	31.34%	32.66%	30.97%
Augmented Payout Ratio	65.30%	57.14%	50.39%	44.34%	47.70%	49.14%	69.90%	89.21%	87.08%	93.07%	77.10%

Frequently Asked Questions About New York Times' Financials

When does New York Times's fiscal year end?

According to the most recent income statement we have on file, New York Times' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has New York Times' net income changed over the last 9 years?

New York Times' net income appears to be on an upward trend, with a most recent value of $293.83 million in 2024, rising from $62.84 million in 2015. The previous period was $232.75 million in 2023. Check out New York Times' forecast to explore projected trends and price targets.

What is New York Times's operating income?

New York Times's total operating income in 2024 was $351.10 million, based on the following breakdown:

Total Gross Profit: $1.28 billion
Total Operating Expenses: $925.31 million

How has New York Times revenue changed over the last 9 years?

Over the last 9 years, New York Times' total revenue changed from $1.58 billion in 2015 to $2.59 billion in 2024, a change of 63.7%.

How much debt does New York Times have?

New York Times' total liabilities were at $914.27 million at the end of 2024, a 3.9% decrease from 2023, and a 42.5% decrease since 2015.

How much cash does New York Times have?

In the past 9 years, New York Times' cash and equivalents has ranged from $100.69 million in 2016 to $319.97 million in 2021, and is currently $199.45 million as of their latest financial filing in 2024.

How has New York Times' book value per share changed over the last 9 years?

Over the last 9 years, New York Times' book value per share changed from 5.11 in 2015 to 11.75 in 2024, a change of 130.2%.

Related Companies

This page (NYSE:NYT) was last updated on 5/28/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

New York Times (NYT) Financials

Frequently Asked Questions About New York Times' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

New York Times (NYT) Financials

Annual Income Statements for New York Times

Quarterly Income Statements for New York Times

Annual Cash Flow Statements for New York Times

Quarterly Cash Flow Statements for New York Times

Annual Balance Sheets for New York Times

Quarterly Balance Sheets for New York Times

Annual Metrics And Ratios for New York Times

Quarterly Metrics And Ratios for New York Times

Frequently Asked Questions About New York Times' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools